February 2026
The global respiratory disease vaccine market size was calculated at USD 101.10 billion in 2025 and is projected to hit around USD 123.77 billion by 2035 with a CAGR of 2.04%.
May 2026
The infectious respiratory disease diagnostics market size is projected to hit around USD 96.57 billion by 2035 from USD 57.55 billion in 2025 with a CAGR of 5.31%.
February 2026
The global foot and mouth disease vaccine market size is expected to reach around USD 3.48 billion by 2035 from USD 1.94 billion in 2025 with a CAGR of 6.02%.
September 2025
The global infectious disease vaccines market size is estimated to hit around USD 72.40 billion by 2034 increasing from USD 36.25 billion in 2024, with a CAGR of 7.17%.
July 2025
The global respiratory antiviral treatment market is surging, with an overall revenue growth expectation of hundreds of millions of dollars from 2025 to 2034.
June 2026
The global celiac disease treatment market size is evaluated at USD 784.59 million in 2025 and is predicted to hit around USD 2,400.49 million by 2035, growing at a CAGR of 11.83%.
June 2026
The global measles, mumps, rubella vaccine market size is estimated at USD 2.02 billion in 2025 and is expected to hit around USD 4.53 billion by 2035, growing at a CAGR of 8.41%.
June 2026
The global non-alcoholic fatty liver disease (NAFLD) drug market size is estimated to hit around USD 35.10 billion by 2035 from USD 21.98 billion in 2025, with a CAGR of 4.79%.
June 2026
The global feline vaccines market size is estimated to hit around USD 3.49 billion by 2035 increasing from USD 1.77 billion in 2025, with a CAGR of 7.02%.
June 2026
The global minimal residual disease (MRD) testing market size is estimated to hit around USD 5.19 billion by 2035 increasing from USD 1.70 billion in 2025, with a CAGR of 11.81%.
June 2026
The global neoantigen cancer vaccine market size is evaluated at USD 475.68 million in 2025 and is predicted to hit around USD 2,023.79 million by 2035, growing at a CAGR of 15.58%.
June 2026
The respiratory disposable market size is calculated at USD 3.15 billion in 2025, and it is expected to hit around USD 7.75 billion by 2035, at a CAGR of 9.42%.
June 2026
The global vaccine storage and packaging market size is estimated to hit around USD 39.24 billion by 2035 increasing from USD 23.29 billion in 2025, with a CAGR of 5.36%.
June 2026
The global chronic disease management market size was estimated at USD 6.61 billion in 2025 and is expected to hit around USD 23.18 billion by 2035, growing at a CAGR of 13.37% from 2026 to 2035.
June 2026
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
June 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
June 2026
The global respiratory disorders treatment market size is estimated to surpass around USD 218.05 billion by 2035 from USD 121.01 billion in 2025 with a CAGR of 6.07%.
June 2026
The mRNA vaccines and therapeutics market size reached USD 116.88 billion in 2025 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
June 2026
The global Huntingtons disease market size was evaluated at USD 1.42 billion in 2025 and is predicted to hit around USD 6.48 billion by 2035, growing at a CAGR of 17.20%.
June 2026
The global vaccine technologies market size is estimated to hit around USD 102.88 billion by 2035 increasing from USD 55.01 billion in 2025, with a CAGR of 6.46%.
June 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 3.75 billion in 2025 with a CAGR of 15.48%.
June 2026
The global respiratory anesthesia consumables market size was evaluated at USD 2.24 billion in 2025 and is predicted to hit around USD 4.58 billion by 2035, growing at a CAGR of 7.41%.
June 2026
The global adult vaccines market size was evaluated at USD 19.97 billion in 2025 and is predicted to hit around USD 50.39 billion by 2035, growing at a CAGR of 9.70%.
May 2026
The global therapeutic respiratory devices market size was valued at USD 25.24 billion by 2025, and is expected to hit around USD 50.36 billion by 2035 with a CAGR of 7.15%.
May 2026
The global disease management apps market size is calculated at USD 10.20 billion in 2025 and is projected to hit around USD 27 billion by 2035 with a CAGR of 10.22%.
May 2026
The global anesthesia and respiratory devices market size is projected to hit around USD 95.26 billion by 2035 from USD 50.45 billion in 2025, with a CAGR of 6.56%.
May 2026
The global diabetic kidney disease market size was valued at USD 3.25 billion in 2025 and is projected to hit around USD 5.23 billion by 2035 with a CAGR of 4.87%.
May 2026
The influenza vaccine market size is expected to increase from USD 9.02 billion in 2025 and is expected to hit around USD 19.19 billion by 2035 with a CAGR of 7.84%.
May 2026
The global graves disease (overactive thyroid) market size is estimated to hit around USD 3.69 billion by 2035 increasing from USD 2.26 billion in 2025, with a CAGR of 5.02%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com